N4 Pharma Plc

AIM:N4P 주식 보고서

시가총액: UK£1.7m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

N4 Pharma 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Nigel Theobald

최고 경영자

UK£82.5k

총 보상

CEO 급여 비율100.0%
CEO 임기10.5yrs
CEO 소유권4.3%
경영진 평균 재임 기간5.2yrs
이사회 평균 재임 기간데이터 없음

최근 관리 업데이트

Should Shareholders Have Second Thoughts About A Pay Rise For N4 Pharma Plc's (LON:N4P) CEO This Year?

Mar 18
Should Shareholders Have Second Thoughts About A Pay Rise For N4 Pharma Plc's (LON:N4P) CEO This Year?

Recent updates

Companies Like N4 Pharma (LON:N4P) Are In A Position To Invest In Growth

Oct 11
Companies Like N4 Pharma (LON:N4P) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About N4 Pharma's (LON:N4P) Cash Burn Situation

Jul 06
Here's Why We're Not Too Worried About N4 Pharma's (LON:N4P) Cash Burn Situation

Should Shareholders Have Second Thoughts About A Pay Rise For N4 Pharma Plc's (LON:N4P) CEO This Year?

Mar 18
Should Shareholders Have Second Thoughts About A Pay Rise For N4 Pharma Plc's (LON:N4P) CEO This Year?

Here's What We Think About N4 Pharma's (LON:N4P) CEO Pay

Mar 01
Here's What We Think About N4 Pharma's (LON:N4P) CEO Pay

Companies Like N4 Pharma (LON:N4P) Can Afford To Invest In Growth

Dec 07
Companies Like N4 Pharma (LON:N4P) Can Afford To Invest In Growth

CEO 보상 분석

Nigel Theobald 의 보수는 N4 Pharma 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Dec 31 2023UK£83kUK£83k

-UK£1m

Sep 30 2023n/an/a

-UK£1m

Jun 30 2023n/an/a

-UK£925k

Mar 31 2023n/an/a

-UK£977k

Dec 31 2022UK£78kUK£78k

-UK£1m

Sep 30 2022n/an/a

-UK£1m

Jun 30 2022n/an/a

-UK£1m

Mar 31 2022n/an/a

-UK£1m

Dec 31 2021UK£75kUK£75k

-UK£2m

Sep 30 2021n/an/a

-UK£2m

Jun 30 2021n/an/a

-UK£2m

Mar 31 2021n/an/a

-UK£2m

Dec 31 2020UK£72kUK£72k

-UK£1m

Sep 30 2020n/an/a

-UK£1m

Jun 30 2020n/an/a

-UK£863k

Mar 31 2020n/an/a

-UK£869k

Dec 31 2019UK£70kUK£70k

-UK£876k

Sep 30 2019n/an/a

-UK£1m

Jun 30 2019n/an/a

-UK£1m

Mar 31 2019n/an/a

-UK£1m

Dec 31 2018UK£70kUK£70k

-UK£1m

보상 대 시장: Nigel 의 총 보상 ($USD 104.92K ) UK 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 358.65K ).

보상과 수익: 회사가 수익성이 없는 동안 Nigel 의 보상이 증가했습니다.


CEO

Nigel Theobald (60 yo)

10.5yrs

테뉴어

UK£82,500

보상

Mr. Nigel James Theobald has been Chief Executive Officer of N4 Pharma Plc since May 3, 2017 and serves as its Executive Director. Mr. Theobald served as the Head of Emerge Marketing Ltd., for Alltracel Ph...


리더십 팀

이름위치테뉴어보상소유권
Nigel Theobald
Founder10.5yrsUK£82.50k4.3%
£ 72.2k
David Templeton
Executive Director & Technical Director5.2yrsUK£51.22k데이터 없음
Luke Cairns
Executive Director4yrsUK£45.72k0.036%
£ 607.2
Rob Harris
Head of CMC Development4.4yrs데이터 없음데이터 없음
Andrew Leishman
Consultant5.5yrs데이터 없음데이터 없음

5.2yrs

평균 재임 기간

60yo

평균 연령

경험이 풍부한 관리: N4P 의 관리팀은 노련하고 경험 (평균 재직 기간 5.1 년)입니다.